ArticlePloS one2025

ABT-263, a BCL-2 inhibitor, selectively eliminates latently HIV-1-infected cells without viral reactivation.

Jeong Eun Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.